| Name: | XERIS PHARMACEUTICALS, INC. |
| Jurisdiction: | New York |
| Legal type: | FOREIGN BUSINESS CORPORATION |
| Status: | Active |
| Date of registration: | 03 Aug 2020 (4 years ago) |
| Entity Number: | 5803115 |
| ZIP code: | 60607 |
| County: | New York |
| Place of Formation: | Delaware |
| Address: | 1375 W Fulton St, Ste 1300, Chicago, IL, United States, 60607 |
| Name | Role | Address |
|---|---|---|
| C T CORPORATION SYSTEM | Agent | 28 LIBERTY STREET, NEW YORK, NY, 10005 |
| Name | Role | Address |
|---|---|---|
| PAUL EDICK | Chief Executive Officer | 1375 W FULTON ST, STE 1300, CHICAGO, IL, United States, 60607 |
| Name | Role | Address |
|---|---|---|
| XERIS PHARMACEUTICALS, INC. | DOS Process Agent | 1375 W Fulton St, Ste 1300, Chicago, IL, United States, 60607 |
| Start date | End date | Type | Value |
|---|---|---|---|
| 2024-08-29 | 2024-08-29 | Address | 1375 W FULTON ST, STE 1300, CHICAGO, IL, 60607, USA (Type of address: Chief Executive Officer) |
| 2024-08-29 | 2024-08-29 | Address | 180 N LASALLE ST, SUITE 1600, SUITE 1600, CHICAGO, IL, 60601, USA (Type of address: Chief Executive Officer) |
| 2020-08-03 | 2024-08-29 | Address | 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Registered Agent) |
| 2020-08-03 | 2024-08-29 | Address | 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Service of Process) |
| Filing Number | Date Filed | Type | Effective Date |
|---|---|---|---|
| 240829001219 | 2024-08-29 | BIENNIAL STATEMENT | 2024-08-29 |
| 220801001154 | 2022-08-01 | BIENNIAL STATEMENT | 2022-08-01 |
| 200803000495 | 2020-08-03 | APPLICATION OF AUTHORITY | 2020-08-03 |
Date of last update: 12 Jan 2025
Sources: New York Secretary of State
